Spitaleri, G <br/><br/>
Phase I/II study of the tumour-targeting human monoclonal antibody-cytokine fusion protein L19-TNF in patients with advanced solid tumours.  [electronic resource] 

 -  Journal of cancer research and clinical oncology  Mar 2013 
 - 447-55 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-1335 
<br/><br/><label>Standard No.: </label>10.1007/s00432-012-1327-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Cohort Studies<br/>Cytokines--administration & dosage<br/>Disease Progression<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Molecular Targeted Therapy--methods<br/>Neoplasms--drug therapy<br/>Recombinant Fusion Proteins--administration & dosage